Susanna J. Park, M. D. , Laura T. Goldsmith, Ph. D. , Joan H

Slides:

Advertisements

Similar presentations

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome Madelon van Wely, Ph.D.,

Advertisements

Impact of chemotherapeutics and advanced testicular cancer or Hodgkin lymphoma on sperm deoxyribonucleic acid integrity Cristian O'Flaherty, Ph.D., Barbara.

Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women Ana Direito, M.D., Sébastien.

Age at menarche: a predictor of diminished ovarian function?

Male contraception Fertility and Sterility

Daily physical activity and hot flashes in the Study of Women's Health Across the Nation (SWAN) Flashes Study Carolyn Gibson, M.P.H., M.S., Karen Matthews,

The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition Lorraine Dennerstein,

The normal variabilities of the menstrual cycle

Fernando Zegers-Hochschild, M.D. Fertility and Sterility

Michael M. Alper, M.D. Fertility and Sterility

Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M

Hepatitis and reproduction

The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation.

Growth rates of ovarian follicles during natural menstrual cycles, oral contraception cycles, and ovarian stimulation cycles Angela R. Baerwald, Ph.D.,

Impact of fatness, insulin, and gynecological age on luteinizing hormone secretory dynamics in adolescent females Josephine Z. Kasa-Vubu, M.D., Vandana.

Medical treatment of ectopic pregnancy: a committee opinion

Failure of the GnRH antagonist ganirelix to block the positive feedback effect of exogenous estrogen in normal women Ioannis E. Messinis, M.D., Ph.D.,

Hakan Cakmak, M. D. , Audra Katz, R. N. , Marcelle I. Cedars, M. D

Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm.

A comparison of blood spot vs

A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data

Improved monofollicular ovulation in anovulatory or oligo-ovulatory women after a low- dose step-up protocol with weekly increments of 25 international.

Oocyte cryopreservation

Prevalence of premature urinary luteinizing hormone surges in women with regular menstrual cycles and its effect on implantation of frozen-thawed embryos

Chao-Chin Hsu, M. D. , Ph. D. , Hsin-Chih Kuo, Ph. D

Angela R. Baerwald, Ph. D. , Olufemi A. Olatunbosun, M. D. , Roger A

Severity of energy-related menstrual disturbances increases in proportion to indices of energy conservation in exercising women Mary Jane De Souza, Ph.D.,

Anastrozole vs. clomiphene citrate in infertile women with ovulatory dysfunction: a phase II, randomized, dose-finding study Donald Tredway, M.D., Ph.D.,

Influence of acupuncture stimulation on pregnancy rates for women undergoing embryo transfer Caroline Smith, Ph.D., Meaghan Coyle, B.Hlth.Sc. (Acup.),

Association between prior appendectomy and/or tonsillectomy in women and subsequent pregnancy rate: a cohort study Li Wei, Ph.D., Thomas MacDonald, M.D.,

René Ecochard, M. D. Ph. D. , Agnes Guillerm, M. D. , René Leiva, M. D

Serum luteinizing hormone levels are markedly increased and significantly correlated with Δ4-androstenedione levels in lean women with polycystic ovary.

Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic.

Tomer Singer, M. D. , David H. Barad, M. D. , M. S

Clomiphene citrate at 50: the dawning of assisted reproduction

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Effect of letrozole at 2. 5 mg or 5

Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in vitro.

Treatment of male idiopathic infertility with recombinant human follicle-stimulating hormone: a prospective, controlled, randomized clinical study Carlo.

Relationship between sleep and secretion of gonadotropin and ovarian hormones in women with normal cycles Sandrine Touzet, M.D., Muriel Rabilloud, M.D.,

Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocol Georg Griesinger, M.D., Anja Dawson, M.D., Askan Schultze-Mosgau,

Mean versus individual hormonal profiles in the menstrual cycle

Hongxia Li, M. D. , Steven T Nakajima, M. D. , Jiangang Chen, M. D

Antoni J. Duleba, M.D., Ibrahim M. Ahmed, M.D. Fertility and Sterility

P-425 Fertility and Sterility Volume 86, Issue 3, (September 2006)

Association of adolescent obesity and lifetime nulliparity—The Study of Women's Health Across the Nation (SWAN) Alex J. Polotsky, M.D., M.S., Susan M.

Cameron Gilbert, M. Sc. , Maria Valois, M. D. , FRCPC, Ph. D

Antecubital vein venous sampling does not distort circulating levels of peptide and sex steroid hormones Michael P. Diamond, M.D., Michael Kruger, M.S.,

L. Scott, J. Bernsten, K. DeLegge, J. Hill, N. Ramsing

The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is.

Fertility and Sterility: an evaluation

Dana Rochester, M. D. , Akas Jain, M. D. , Alex J. Polotsky, M. D

Paolo Moghetti, M.D. Fertility and Sterility

Validation of a prediction model for the follicle-stimulating hormone response dose in women with polycystic ovary syndrome Madelon van Wely, Ph.D.,

Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins:

Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing.

Female cancer survivors exposed to alkylating-agent chemotherapy have unique reproductive hormone profiles Lauren Johnson, M.D., M.S.C.E., Mary D. Sammel,

Association of endometriosis with body size and figure

Current evaluation of amenorrhea

Inappropriate gonadotropin secretion in polycystic ovary syndrome

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

Serum anti-Mullerian hormone dynamics during stimulated cycles by aromatase inhibitor anastrozole and clomiphene citrate in women with infertility H.-H.

Ronald M. Yang, M. D. , Richard A. Fefferman, M. D. , Charles E

Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function David H. Barad, M.D., M.S., Andrea Weghofer,

In vitro sildenafil citrate use as a sperm motility stimulant

Soluble HLA-G in the peritoneal fluid of women with endometriosis

Anastrozole single-dose protocol in women with oligo- or anovulatory infertility: results of a randomized phase II dose–response study Donald Tredway,

Microdose gonadotropin-releasing hormone agonist in the absence of exogenous gonadotropins is not sufficient to induce multiple follicle development

Progesterone level and progesterone/estradiol ratio on the day of hCG administration: detrimental cutoff levels and new treatment strategy Eman A. Elgindy,

Oocyte retrieval timing based on spontaneous luteinizing hormone surge during natural cycle in vitro fertilization treatment Daniel Bodri, M.D., M.Sc.,

Presentation transcript:

Characteristics of the urinary luteinizing hormone surge in young ovulatory women Susanna J. Park, M.D., Laura T. Goldsmith, Ph.D., Joan H. Skurnick, Ph.D., Andrea Wojtczuk, M.S., Gerson Weiss, M.D. Fertility and Sterility Volume 88, Issue 3, Pages 684-690 (September 2007) DOI: 10.1016/j.fertnstert.2007.01.045 Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Urinary excretion patterns in ovulatory women (n = 40). (A) Luteinizing hormone (LH). (B) Follicle-stimulating hormone (FSH). (C) Estrone conjugate (E1C). (D) Pregnanediol-3-glucuronide (PDG). Data are plotted wherein day 0 is the day of the LH peak. Three women were omitted because they missed one urine collection midcycle such that the peak of the LH surge could not be determined. Park. Characteristics of urinary LH surge. Fertil Steril 2007. Fertility and Sterility 2007 88, 684-690DOI: (10.1016/j.fertnstert.2007.01.045) Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Types of onset of the luteinizing hormone surge. For simplicity, the data of individual women representative of each pattern are depicted. (A) Rapid onset of 1-day duration. (B) Gradual onset of greater than 1-day duration. Park. Characteristics of urinary LH surge. Fertil Steril 2007. Fertility and Sterility 2007 88, 684-690DOI: (10.1016/j.fertnstert.2007.01.045) Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions

Figure 3 Types of luteinizing hormone surge configurations. For simplicity, the data of individual women representative of each pattern are depicted. (A) Spike. (B) Biphasic. (C) Plateau. Park. Characteristics of urinary LH surge. Fertil Steril 2007. Fertility and Sterility 2007 88, 684-690DOI: (10.1016/j.fertnstert.2007.01.045) Copyright © 2007 American Society for Reproductive Medicine Terms and Conditions